“…The interest in the design and synthesis of novel anticancer therapeutics is also present in the manuscript by Beloglazina and co-workers from Moscow, Russia, who reported the synthesis of a series of S-, O-and Se-containing dispirooxoindoles through 1,3-dipolar cycloaddition of azomethine ylides, assayed their cytotoxicity against different tumor cell lines and performed an in silico study to rationalize the results [7]. The group of Simone and co-workers from Callaghan, Australia, reported the synthesis, glycosidase inhibition and anticancer properties of highly chlorinated benzamide analogues bearing a boronpinacolate ester group, with the perspective to use them in boron neutron capture therapy (BNCT) [8].…”